Abstract
This study establishes the chemically induced hypoxia OcclusionChip assay as a reliable clinical tool for evaluating red blood cell deformability in sickle cell disease, with potential to improve personalized treatment strategies and outcomes.
Funding Information
  • Small Business Innovation Research (R41HL172662, R42DK119048, R44HL140739)
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • American Society of Hematology
  • Fogarty International Center (D43TW012260)